This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. (MRNA) shed 6.45% to $171.14 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 1.19% to 12,493.93 and Dow Jones Industrial Average falling 0.18% to 32,774.41. This was the stock's third consecutive day of losses. Moderna Inc. closed $326.35 short of its 52-week high ($497.49), which the company achieved on August 10th.
The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc. (ABBV) fell 0.06% to $140.25, Amgen Inc. (AMGN) rose 0.43% to $248.36, and AstraZeneca PLC ADR (AZN.LN) rose 1.18% to $65.89. Trading volume (5.1 M) remained 187,742 below its 50-day average volume of 5.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 9, 2022.
(END) Dow Jones Newswires
August 09, 2022 16:32 ET (20:32 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.